Aptevo Therapeutics (AP82) Q2 2024 Earnings Report
DE:AP82 Q2 2024 EPS Results
- Actual EPS
- -EUR 19,888.93
- Consensus EPS
- -EUR 22,985.41
- Beat/Miss
- Beat by +EUR 3,096.48
- One Year Ago EPS
- -EUR 644,544.36
DE:AP82 Q2 2024 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- EUR 0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/08/2024
- Time
- Before Open
- Conference Call
- Thursday, August 8, 2024
DE:AP82 Upcoming Earnings
Aptevo Therapeutics's next earnings date is estimated for November 5, 2026, based on past reporting schedules.
Q2 2024 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:AP82 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 05, 2026 | 2026 (Q3) | -3.32- | -35.89 | ― | ― |
| Aug 14, 2026 | 2026 (Q2) | -5.38-4.75 | -135.19 | 96.49% (+130.44) | |
| May 07, 2026 | 2026 (Q1) | -5.01-5.73 | -1413.05 | 99.59% (+1407.32) | |
| Mar 26, 2026 | 2025 (Q4) | -5.311506.10 | -2877.6 | 152.34% (+4383.70) | |
| Nov 06, 2025 | 2025 (Q3) | -33.64-35.89 | -5716.58 | 99.37% (+5680.69) | |
| Aug 11, 2025 | 2025 (Q2) | -1339.02-135.19 | -19888.93 | 99.32% (+19753.74) | |
| May 15, 2025 | 2025 (Q1) | -1355.11-1413.05 | -118499.93 | 98.81% (+117086.88) | |
| Feb 14, 2025 | 2024 (Q4) | -2494.57-2877.60 | -159945.14 | 98.20% (+157067.53) | |
| Nov 07, 2024 | 2024 (Q3) | -6788.44-5716.58 | -262009.9 | 97.82% (+256293.32) | |
| Aug 08, 2024 | 2024 (Q2) | -22985.41-19888.93 | -644544.36 | 96.91% (+624655.43) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
